Researchers Track Trends for Oncotype DX Breast Cancer Recurrence Test Following Medicare Coverage | GenomeWeb

NEW YORK (GenomeWeb) – In JAMA Oncology, researchers from Duke University and elsewhere looked at the uptake and use of Genomic Health's Oncotype DX breast cancer recurrence assay in Medicare beneficiaries in the years following its coverage approval.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.